Subject characteristics | All patients (n=10) |
Demographic characteristics | |
Age (years), mean±SD | 68.8±13.1 |
Sex, female, n (%) | 4 (40) |
Race | Caucasian (100%) |
Hispanic | 0 |
Risk factors, n (%) | |
Hypertension | 7 (70) |
Diabetes | 0 |
Hyperlipidaemia | 2 (20) |
Previous ischaemic stroke/transient ischaemic attack | 0 |
Smoking (current and former within 5 years) | 1 (10) |
Alcohol (two or fewer drinks/day) | 6 (60) |
Medication, n (%) | |
Antiplatelet | 3 (30) |
Anticoagulant | 0 |
Lipid-lowering | 4 (30) |
Blood pressure medication | 5 (50) |
NIHSS, median (IQR 25–75) | 1.5 (0–4) |
Time intervals (min), median (IQR 25–75) | |
Last known well to triage | 111.5 (40.0–698.0) |
Last known well to blood draw | 297.5 (278.8–869.3) |
Stroke location, n (%) | |
Left cerebrum | 3 (30) |
Left cerebrum and cortical cerebrum | 2 (20) |
Left cerebrum and deep cerebrum | 2 (20) |
Right cerebrum | 1 (10) |
None | 2 (20) |
Vascular territory, n (%) | |
Left ACA | 2 (20) |
Left MCA | 6 (60) |
Right ACA and right PCA | 1 (10) |
Acute treatment with intravenous tPA, n (%) | |
Intravenous tPA | 4 (40) |
None | 6 (60) |
Days of hospital stay, median (IQR 25–75) | 2.5 (1.0–4.3) |
Last known well indicates the time before hospital arrival at which the patient was last known to be without the signs and symptoms of the current stroke.
ACA, anterior cerebral artery; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; PCA, posterior cerebral artery; tPA, tissue plasminogen activator.